1.On the Characteristics and Construction of Identifying Concepts in Traditional Chinese Medicine
Journal of Traditional Chinese Medicine 2026;67(15):1585-1591
The construction of identifying concepts in traditional Chinese medicine (TCM) represents a fundamental and prerequisite task for establishing an independent knowledge system of TCM. By defining the principles for the extraction and the methods for constructing TCM identifying concepts, this paper proposes that such concepts should possess the characteristics of being framework-oriented, autonomous, extensible, inheritable, and cross-disciplinary, and should follow a structural framework of "worldview-thinking mode-methodology". Based on this framework, typical TCM identifying concepts, including qi, yin-yang, five elements, visceral manifestation, meridians and collaterals, body fluids, xiang (manifestation), four diagnostic methods, pattern differentiation, preventive treatment of disease, treating disease by seeking the root cause, prescription-syndrome, four natures and five flavors, and combination of medicinals, are extracted from four classical texts,i.e. The Inner Canon of Yellow Emperor (《黄帝内经》), The Classic of Difficult Issues (《难经》), Treatise on Cold Damage and Miscellaneous Diseases (《伤寒杂病论》), and Shen Nong's Classic of the Materia Medica (《神农本草经》). Their interrelationships are further elucidated. Exploring a pathway for constructing TCM identifying concepts will not only facilitate the development of an independent know-ledge system of TCM and promote its inheritance and innovative development, but also provide a reference for the establishment of independent knowledge systems in other disciplines.
2.On the Characteristics and Construction of Identifying Concepts in Traditional Chinese Medicine
Journal of Traditional Chinese Medicine 2026;67(15):1585-1591
The construction of identifying concepts in traditional Chinese medicine (TCM) represents a fundamental and prerequisite task for establishing an independent knowledge system of TCM. By defining the principles for the extraction and the methods for constructing TCM identifying concepts, this paper proposes that such concepts should possess the characteristics of being framework-oriented, autonomous, extensible, inheritable, and cross-disciplinary, and should follow a structural framework of "worldview-thinking mode-methodology". Based on this framework, typical TCM identifying concepts, including qi, yin-yang, five elements, visceral manifestation, meridians and collaterals, body fluids, xiang (manifestation), four diagnostic methods, pattern differentiation, preventive treatment of disease, treating disease by seeking the root cause, prescription-syndrome, four natures and five flavors, and combination of medicinals, are extracted from four classical texts,i.e. The Inner Canon of Yellow Emperor (《黄帝内经》), The Classic of Difficult Issues (《难经》), Treatise on Cold Damage and Miscellaneous Diseases (《伤寒杂病论》), and Shen Nong's Classic of the Materia Medica (《神农本草经》). Their interrelationships are further elucidated. Exploring a pathway for constructing TCM identifying concepts will not only facilitate the development of an independent know-ledge system of TCM and promote its inheritance and innovative development, but also provide a reference for the establishment of independent knowledge systems in other disciplines.
3.Huashi Baidu Granules Treat Influenza Viral Pneumonia by Regulating Gut-Lung Axis
Qijing LI ; Hanhui HUANG ; Yurong DENG ; Ao'ao WANG ; Jianliang LI ; Jianhui SUN ; Liyu HAO ; Zongyuan LI ; Guimin LIU ; Hongmei LI ; Luqi HUANG
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(23):59-69
ObjectiveTo explore the mechanism of Huashi Baidu granules in treating influenza A (H1N1) virus infection based on the gut-lung axis. MethodsBALB/c mice were randomly assigned into a blank control group, a model control group, a positive control (oseltamivir phosphate capsules, 19.5 mg·kg-1) group, and a Huashi Baidu granules (17.81 g·kg-1) group. Mice in other groups except the blank control group were instilled nasally by H1N1 viral fluid for the modeling of influenza viral pneumonia and treated with corresponding drugs once daily by gavage for 5 consecutive days. The mouse lung index was calculated, and pathological changes in the lung and colon tissue were observed. Western blot was employed to quantify the expression levels of nucleotide-binding oligomeric domain-like receptor protein 3 (NLRP3), cysteinyl aspartate-specific proteinase -1 (Caspase-1), apoptosis-associated Speck-like protein containing a CARD (ASC), gasdermin D (GSDMD), interleukin-18 (IL-18), IL-1β, and colonic tight junction protein 1 (CLDN1), and Occludin in the lung and colon tissue. Non-targeted metabolomics was employed to analyze the metabolic profiles of the lung tissue and intestinal contents. The 16S rRNA sequencing was performed to analyze the gut microbiota structure in intestinal contents. Enzyme-linked immunosorbent assay (ELISA) was employed to measure the 5-hydroxytryptamine (5-HT) levels in the serum, lung tissue, and colon tissue. ResultsCompared with the blank control group, the model control group showed elevated lung index, marked inflammatory cell infiltration and alveolar structural destruction in the lung tissue, obvious inflammatory cell infiltration and mucosal epithelial damage in the colon tissue, upregulated protein levels of NLRP3 inflammasome pathway proteins NLRP3, Caspase-1, GSDMD, IL-1β, and IL-18 in the lung and colon tissue (P<0.05, P<0.01), downregulated protein levels of CLDN1 and Occludin in the colon tissue (P<0.05, P<0.01). Compared with the model control group, Huashi Baidu Granules reduced the lung index (P<0.01), alleviated pathological damage in the lungs and colon, inhibited the expression of NLRP3, Caspase-1, GSDMD, IL-1β, and IL-18 in lung and colon tissue (P<0.05, P<0.01), and upregulated the expression of CLDN1 and Occludin in the colon tissue (P<0.05, P<0.01). Metabolomics analysis showed that Huashi Baidu Granules downregulated the 5-HT pathway and arachidonic acid metabolism pathway in the lung and colon tissue, while upregulating nucleotide metabolism and TCA cycle. Compared with the blank control group, the model control group exhibited elevated levels of 5-HT in the serum, lung tissue, and colon tissue (P<0.01). The intervention with Huashi Baidu Granules lowered the levels of 5-HT in the serum (P<0.05) and the lung and colon tissue (P<0.01). Huashi Baidu Granules increased the diversity of gut microbiota, enriched beneficial bacteria such as Blautia, and inhibited pathogenic bacteria such as Desulfovibrio. ConclusionHuashi Baidu Granules significantly alleviate lung inflammation and pathological damage in mice infected with influenza A (H1N1) virus, reshape the intestinal microecology, and repair the intestinal barrier. It may exert cross-organ regulation by inhibiting the cascade of "gutogenic 5-HT release-circulatory transport-pulmonary 5-HT receptor activation-NLRP3 inflammasome assembly." It exerts therapeutic effects on influenza viral pneumonia through the gut-lung axis. This study provides a modern biological interpretation for the TCM theories of interior-exterior relationship between the lung and large intestine and simultaneous treatment of the lung and intestine.
4.Promoting international acceptance of clinical studies about traditional Chinese medicine interventions
Ling LI ; Xiaochao LUO ; Jiali LIU ; Minghong YAO ; Yanmei LIU ; Yu MA ; Luqi HUANG ; Xin SUN
Science of Traditional Chinese Medicine 2025;3(1):1-7
Promoting the international acceptance of clinical studies about traditional Chinese medicine (TCM) interventions is a key strategy for internationalization of TCM. However, the complexities of TCM interventions—in terms of the theories, practice patterns, and components—pose challenges to the design and implementation of clinical studies that are well accepted by the international community. This article summarized the current status of clinical studies about TCM interventions that were published in international journals, explored underlying barriers hindering the international acceptance, and discussed potential strategies for future development.
5.Promoting international acceptance of clinical studies about traditional Chinese medicine interventions
Ling LI ; Xiaochao LUO ; Jiali LIU ; Minghong YAO ; Yanmei LIU ; Yu MA ; Luqi HUANG ; Xin SUN
Science of Traditional Chinese Medicine 2025;3(1):1-7
Promoting the international acceptance of clinical studies about traditional Chinese medicine (TCM) interventions is a key strategy for internationalization of TCM. However, the complexities of TCM interventions—in terms of the theories, practice patterns, and components—pose challenges to the design and implementation of clinical studies that are well accepted by the international community. This article summarized the current status of clinical studies about TCM interventions that were published in international journals, explored underlying barriers hindering the international acceptance, and discussed potential strategies for future development.
6.Promoting international acceptance of clinical studies about traditional Chinese medicine interventions
Ling LI ; Xiaochao LUO ; Jiali LIU ; Minghong YAO ; Yanmei LIU ; Yu MA ; Luqi HUANG ; Xin SUN
Science of Traditional Chinese Medicine 2025;3(1):1-7
Promoting the international acceptance of clinical studies about traditional Chinese medicine (TCM) interventions is a key strategy for internationalization of TCM. However, the complexities of TCM interventions—in terms of the theories, practice patterns, and components—pose challenges to the design and implementation of clinical studies that are well accepted by the international community. This article summarized the current status of clinical studies about TCM interventions that were published in international journals, explored underlying barriers hindering the international acceptance, and discussed potential strategies for future development.
7.Textual Research on the Efficacy of Ligusticum sinense cv.Fuxiong
Feng GAO ; Fangyuan MU ; Jixin LI ; Jiaxin TIAN ; Kunyu LI ; Haiguang MA ; Luqi HUANG ; Jin ZHANG
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(10):22-26
Ligusticum sinense cv.Fuxiong derived from"Xiongqiong",and in the Song Dynasty's Tai Ping Hui Min He Ji Ju Fang,it was already distinguished from Chuanxiong Rhizoma in usage.Doctors in the Ming Dynasty further clarified the differences in efficacy between the two.However,with the widespread circulation of Chuanxiong Rhizoma,Ligusticum sinense cv.Fuxiong gradually became marginalized,serving as a substitute,and is now only cultivated and used in small quantities within Jiangxi Province.This article reviewed the prescriptions and the ancient Chinese medical books that have records of Ligusticum sinense cv.Fuxiong,analyzed its specific applications alongside Chuanxiong Rhizoma in prescriptions and case studies to elucidate their differences in efficacy:Ligusticum sinense cv.Fuxiong is pungent and has strong dispersing power and is good at unblocking meridians and promoting qi circulation,which is suitable for excessive syndromes;Chuanxiong Rhizoma is good at promoting blood circulation and relieving pain,and is good at regulating and nourishing,which is suitable for patients with deficiency syndromes,aiming to provide insights and recommendations for the further development and rational clinical medication of Ligusticum sinense cv.Fuxiong.
8.Effect of drug-eluting bead DACE combined with systemic treatment for hepatocellular carcinoma in different locations
Xingli YAN ; Zhen LI ; Jie LI ; Luqi HU ; Yifan LI ; Yanan ZHAO ; Yuyuan ZHANG ; Junying LIU ; Pengchao ZHAN ; Xin LI ; Peijie LYU ; Yancang ZHANG
Chinese Journal of Interventional Imaging and Therapy 2025;22(4):238-242
Objective To investigate the effect of drug-eluting bead DACE(DEB-TACE)combined with systemic treatment for hepatocellular carcinoma(HCC)in different locations.Methods A total of 204 HCC patients who underwent DEB-TACE combined with systemic therapy(targeted and immunotherapy)were retrospectively collected.According to the anatomical location of HCC,86 cases with lesions located at the main trunk of portal vein(PV)or within 1 cm of the first PV branch were classified into central type group,while 118 cases with lesions located at the other areas were classified as peripheral type group.Follow-up was regularly performed after DEB-TACE until August,2024.The objective response rate(ORR)and disease control rate(DCR)at 1,3,6 and 12 months after DEB-TACE,also patients'progression-free survival(PFS)and overall survival(OS)were compared between groups.Results All patients were followed up for a median of 32.6 months,during which 164 cases died.Significant differences of ORR at 1 and 3 months after DEB-TACE(77.91%[67/86]vs.89.83%[106/118],34.88%[30/86]vs.54.24%[64/118])and DCR at 3 and 6 months after DEB-TACE(51.16%[44/86]vs.66.95%[79/118],34.88%[30/86]vs.50.00%[59/118])were found between groups(all P<0.05).Patients'PFS(30.18[9.12,48.54]months)and OS(37.36[17.79,56.68])in peripheral type group were better than those in central type group(20.11[11.35,28.87]months and 23.24[3.11,43.47]months,x2=3.971,4.162,P=0.048,0.041).Conclusion The effect of DEB-TACE combined with systemic treatment for peripheral type HCC was better than for central type HCC.
9.Textual Research on the Efficacy of Ligusticum sinense cv.Fuxiong
Feng GAO ; Fangyuan MU ; Jixin LI ; Jiaxin TIAN ; Kunyu LI ; Haiguang MA ; Luqi HUANG ; Jin ZHANG
Chinese Journal of Information on Traditional Chinese Medicine 2025;32(10):22-26
Ligusticum sinense cv.Fuxiong derived from"Xiongqiong",and in the Song Dynasty's Tai Ping Hui Min He Ji Ju Fang,it was already distinguished from Chuanxiong Rhizoma in usage.Doctors in the Ming Dynasty further clarified the differences in efficacy between the two.However,with the widespread circulation of Chuanxiong Rhizoma,Ligusticum sinense cv.Fuxiong gradually became marginalized,serving as a substitute,and is now only cultivated and used in small quantities within Jiangxi Province.This article reviewed the prescriptions and the ancient Chinese medical books that have records of Ligusticum sinense cv.Fuxiong,analyzed its specific applications alongside Chuanxiong Rhizoma in prescriptions and case studies to elucidate their differences in efficacy:Ligusticum sinense cv.Fuxiong is pungent and has strong dispersing power and is good at unblocking meridians and promoting qi circulation,which is suitable for excessive syndromes;Chuanxiong Rhizoma is good at promoting blood circulation and relieving pain,and is good at regulating and nourishing,which is suitable for patients with deficiency syndromes,aiming to provide insights and recommendations for the further development and rational clinical medication of Ligusticum sinense cv.Fuxiong.
10.Effect of drug-eluting bead DACE combined with systemic treatment for hepatocellular carcinoma in different locations
Xingli YAN ; Zhen LI ; Jie LI ; Luqi HU ; Yifan LI ; Yanan ZHAO ; Yuyuan ZHANG ; Junying LIU ; Pengchao ZHAN ; Xin LI ; Peijie LYU ; Yancang ZHANG
Chinese Journal of Interventional Imaging and Therapy 2025;22(4):238-242
Objective To investigate the effect of drug-eluting bead DACE(DEB-TACE)combined with systemic treatment for hepatocellular carcinoma(HCC)in different locations.Methods A total of 204 HCC patients who underwent DEB-TACE combined with systemic therapy(targeted and immunotherapy)were retrospectively collected.According to the anatomical location of HCC,86 cases with lesions located at the main trunk of portal vein(PV)or within 1 cm of the first PV branch were classified into central type group,while 118 cases with lesions located at the other areas were classified as peripheral type group.Follow-up was regularly performed after DEB-TACE until August,2024.The objective response rate(ORR)and disease control rate(DCR)at 1,3,6 and 12 months after DEB-TACE,also patients'progression-free survival(PFS)and overall survival(OS)were compared between groups.Results All patients were followed up for a median of 32.6 months,during which 164 cases died.Significant differences of ORR at 1 and 3 months after DEB-TACE(77.91%[67/86]vs.89.83%[106/118],34.88%[30/86]vs.54.24%[64/118])and DCR at 3 and 6 months after DEB-TACE(51.16%[44/86]vs.66.95%[79/118],34.88%[30/86]vs.50.00%[59/118])were found between groups(all P<0.05).Patients'PFS(30.18[9.12,48.54]months)and OS(37.36[17.79,56.68])in peripheral type group were better than those in central type group(20.11[11.35,28.87]months and 23.24[3.11,43.47]months,x2=3.971,4.162,P=0.048,0.041).Conclusion The effect of DEB-TACE combined with systemic treatment for peripheral type HCC was better than for central type HCC.

Result Analysis
Print
Save
E-mail